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Abstract
Background: Thyroid function changes during pregnancy and maternal thyroid dysfunction have
been associated with adverse outcomes. Our aim was to evaluate thyroid hormones levels in
pregnant women resident in Aragon, Spain.
Findings: Samples for 1198 pregnant women with no apparent thyroid disorders were analyzed,
using paramagnetic microparticle and chemiluminescent detection technologies, in order to
determine levels of thyroid stimulating hormone (TSH), free triiodothyronine (FT3), free thyroxine
(FT4), thyroid peroxidase antibodies (TPO-Ab), and thyroglobulin antibodies (Tg-Ab). Of the
women in our sample, 85.22% had normal values for TPO-Ab and Tg-Ab and 14.77% had results
revealing the presence of autoimmune diseases of the thyroid. The thyroid hormone reference
values obtained according to gestational age (in brackets) were as follows: for free T3, values were
3.38 ± 0.52 pg/mL (<11 weeks), 3.45 ± 0.54 pg/mL (11-20 weeks), 3.32 ± 0.43 pg/mL (21-30 weeks),
3.21 ± 0.53 pg/mL (31-36 weeks), and 3.23 ± 0.41 pg/mL (>36 weeks); for free T4, values were 1.10
± 0.14 ng/dL (<10 weeks), 1.04 ± 0.14 ng/dL (11-20 weeks), 0.93 ± 0.12 ng/dL (21-30 weeks), 0.90
± 0.13 ng/dL (31-36 weeks), and 0.80 ± 0.21 ng/dL (>36 weeks); and for TSH, values were (μIU/
mL): 1.12 ± 0.69 (<10 weeks), 1.05 ± 0.67 (11-20 weeks), 1.19 ± 0.60 (21-30 weeks), 1.38 ± 0.76
(31-36 weeks), and 1.46 ± 0.72 (>36 weeks).
Conclusion: Pregnant women with normal antibody values according to gestational age had values
for FT4 and TSH, but not for FT3, that differed to a statistically significant degree. The values we
describe can be used as reference values for the Aragon region of Spain.
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Background
A dysfunctional thyroid gland during pregnancy can affect
both mother and fetus [1-3]. One example is the maternal
hypothyroidism and hyperthyroidism occurring at the
beginning and end of pregnancy that may increase the risk
of low birth weight and the likelihood of a Caesarean sec-
tion [4,5]. For this reason, correct diagnosis is important
so that any thyroid dysfunction can be treated. Nonethe-
less, the normal physiological changes that occur in preg-
nancy can make interpreting the test difficult [6],
especially when there are no established reference levels
for these hormones, as with the Aragon population.
Between 5% and 15% of pregnant women experience thy-
roid abnormalities, a fact which justifies screening by
means of clinical laboratory testing [7,8]. In Spain, steady
immigration flows in recent years have led to the develop-
ment of a multiethnic population. Consequently, previ-
ous thyroid hormone reference values may be unreliable,
since reference values tend to vary according to ethnic
group [9-11].
The aim of this study was to evaluate 5 thyroid parameters
for a normal pregnant population (median age, 31.47
years) resident in the Aragon region of Spain. The param-
eters measured were thyroid-stimulating hormone (TSH),
free triiodothyronine (T3), free thyroxine (T4), thyroid
peroxidase antibodies (TPO-Ab), and thyroglobulin anti-
bodies (Tg-Ab).
Methods
The study design and protocol were reviewed and
approved by the independent ethics committee of Hospi-
tal Universitario Miguel Servet of Aragon, Spain, in
accordance with the Declaration of Helsinki and the
Nuremberg Code. Subjects in the study gave their
informed consent.
Included in the study were 1198 pregnant women, with
no apparent thyroid disorders, resident in the Aragon
region of Spain and belonging to 5 self-reported ethnic
groups, as follows: white; American-Indian; Arab; black;
and Asian. The samples were analyzed using a high-per-
formance immunoassay analyzer that uses paramagnetic
microparticle and chemiluminescent detection technolo-
gies (ARCHITECT i2000SR, Abbott Diagnostics) [12]. The
hormone samples were combined in the sample diluent
with paramagnetic microparticles coated with anti-hor-
mone antibodies to which the hormones bound. An
acridinium-labeled anti-hormone conjugate was added
following washing, then pre-trigger and trigger solutions
were added to the reaction mixture. The resulting chemi-
luminescent reaction was measured in relative light units
(RLUs). In our case, there was a directly proportional rela-
tionship between the amount of thyroid hormone present
in the sample and the RLUs detected by the optical sys-
tem.
The same method and procedure was used for the anti-
bodies, with the only difference being that anti-human
IgG acridinium-labeled conjugate was used instead of the
anti-hormone conjugate.
The 5 analytes under consideration were determined in
serum, with results expressed in units as follows (manu-
facturer reference limits in brackets): TSH in μUI/mL
(4.94), free T3 in pg/mL (3.71), free T4 in ng/dL (1.48),
TPO-Ab in IU/mL (<5.61), and Tg-Ab in IU/mL (<4.11).
Results for the 5 parameters (3 thyroid hormones and 2
thyroid antibodies) were expressed as mean (SD),
median, 2.5th percentile, and 97.5th percentile for 5 ges-
tational age intervals (less than 11 weeks, 11-20 weeks,
21-30 weeks, 31-36 weeks, and more than 36 weeks). Sta-
tistical analysis was performed using SPSS Version 13.0.
The one-way ANOVA test was used to compare differences
for the 5 gestational stages for a level of significance of P <
.05.
Results
Data for a total 1198 pregnant residents of Aragon (Spain)
from a range of different ethnic backgrounds were ana-
lyzed. The sample population composition according to
ethnic group was follows: white (85.16%); American-
Indian (6.56%); Arab (3.61%); black (3.12%); and Asian
(1.57%). Age range was 15 to 45 years, and the median
was 31.47 years.
Thyroid antibody levels were normal in 1021 women, as
follows: 330 women who were less than 11 weeks' preg-
nant; 200 women who were 11-20 weeks' pregnant; 208
women who were 21-30 weeks' pregnant; 269 women
who were 31-36 weeks' pregnant; and 14 women who
were more than 36 weeks' pregnant.
Table 1 shows the mean, standard deviation, median,
2.5th percentile, and 97.5th percentile for the 3 thyroid
hormones and 2 thyroid antibodies according to gesta-
tional stage.
Figures 1, 2, 3 show the median values for each of the 5
gestational stages for TSH, free T3, and free T4, respec-
tively. Figure 1 shows how median TSH values increased
with gestational stage, with statistically significant differ-
ences for the gestational intervals defined (P < .05). In Fig-
ure 2, on the other hand, it can be observed that median
free T3 values hardly changed from one interval to the
next, with no statistically significant differences betweenBMC Research Notes 2009, 2:237 http://www.biomedcentral.com/1756-0500/2/237
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Table 1: Thyroid Hormone and Thyroid Antibody Values According to Gestational Age
Thyroid Hormones/Antibodies Gestional Age, wka Mean Median 2.5th %ile 97.5th
%ile
Thyroid-stimulating hormone (μUI/mL) <11 1.12 ± 0.69 1.00 0.10 2.65
11 to 20 1.05 ± 0.67 0.92 0.03 2.57
21 to 30 1.19 ± 0.60 1.12 0.12 2.64
31 to 36 1.38 ± 0.76 1.29 0.23 3.56
>36 1.46 ± 0.72 1.43 0.36 -
Free triiodothyronine (pg/mL) <11 3.38 ± 0.52 3.37 2.34 4.34
11 to 20 3.45 ± 0.54 3.49 2.24 4.43
21 to 30 3.32 ± 0.43 3.33 2.47 4.18
31 to 36 3.21 ± 0.53 3.24 2.25 4.16
>36 3.23 ± 0.41 3.28 2.59 -
Free thyroxine (ng/dL) <11 1.10 ± 0.14 1.10 0.83 1.38
11 to 20 1.04 ± 0.14 1.02 0.77 1.34
21 to 30 0.93 ± 0.12 0.93 0.70 1.14
31 to 36 0.90 ± 0.13 0.89 0.66 1.17
>36 0.80 ± 0.21 0.85 0.17 -
<11 0.14 ± 0.21 0.09 0.00 0.68
Thyroid peroxidase antibodies (UI/mL) 11 to 20 0.17 ± 0.33 0.09 0.00 1.04
21 to 30 0.15 ± 0.23 0.09 0.00 0.89
31 to 36 0.19 ± 0.45 0.09 0.00 1.27
>36 0.09 ± 0.08 0.08 0.00 -
Thyroglobulin antibodies (UI/mL) <11 1.04 ± 0.65 0.82 0.41 3.11
11 to 20 1.08 ± 0.70 0.86 0.34 3.31
21 to 30 0.92 ± 0.55 0.75 0.37 2.60
31 to 36 0.89 ± 0.52 0.76 0.38 2.45
>36 0.90 ± 0.53 0.83 0.46 -
a <11 weeks (n = 330); 11 to 20 weeks (n = 200); 21 to 30 weeks (n = 208); 31 to 36 weeks (n = 269); >36 weeks (n = 14).BMC Research Notes 2009, 2:237 http://www.biomedcentral.com/1756-0500/2/237
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the gestational intervals defined. Finally, Figure 3 shows
how median free T4 values fell as gestational age advanced
(P < .05).
It was observed that women in the population with anti-
body levels that were normal for the gestational stage had
statistically significant different TSH and free T4 values (P
< .001), but not free T3 values (P > .05). In relation to the
age of the mother, statistically significant differences were
only evident for TSH values (P < .05).
Table 2 shows the values obtained for the 5 parameters
according to pregnancy trimester, with the ANOVA reveal-
ing significant differences between the 3 thyroid hor-
mones for each trimester (P < .001).
A total of 177 pregnant women had raised TPO-Ab and
Tg-Ab values in gestational stages as follows: 63 women
who were less than 11 weeks' pregnant; 33 women who
were 11-20 weeks' pregnant; 34 women who were 21-30
weeks' pregnant; 45 women who were 31-36 weeks' preg-
nant; and 2 women who were more than 36 weeks' preg-
nant. Values for TSH, free T3, and free T4 for these women
are given in Table 3.
Pregnant women with high TPO-Ab and Tg-Ab values had
a mean TSH value that was higher than in pregnant
women with normal TPO-Ab and Tg-Ab values, for all the
gestational ages defined with 1 exception; this was the last
interval (more than 36 weeks' pregnant), where the mean
TSH value was lower. The free T3 mean value was lower in
4 gestation intervals (11-20 weeks, 21-30 weeks, less than
11 weeks, and more than 36 weeks) and slightly higher in
1 gestation interval (31-36 weeks). As for the mean free T4
value, this was slightly lower in all the intervals with the
exception of the last gestation interval (more than 36
Boxplot. Median value for thyroid-stimulating hormone according to gestational age Figure 1
Boxplot. Median value for thyroid-stimulating hormone according to gestational age. *P < .05. The circles and 
stars represent distant values and outliers, respectively, and the adjacent numbers indicate the gestational week of the patient.
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weeks), where it was slightly higher, and the second last
gestation interval (31-36 weeks), where the mean value
was the same as that for pregnant women with normal
TPO-Ab and Tg-Ab levels.
In terms of ethnic origins, 92.7% of the women with high
TPO-Ab and Tg-Ab values were white, 2.81% were Arab,
2.81% were American-Indian, 1.12% were black, and
0.56% were Asian.
Conclusion
We measured TSH, free T3, free T4, TPO-Ab and Tg-Ab lev-
els for a sample population resident in the Aragon region
of Spain consisting of 1198 pregnant women representing
different ethnic groups.
For the 1021 pregnant women with normal TPO-Ab and
Tg-Ab levels, TSH and free T4 values were different
depending on the pregnancy trimester, with statistically
significant differences in these values for the 3 trimesters
(P < .001), but not in free T3 values. It is important to have
reference values for the 3 trimesters, particularly for TSH
and free T4, and particularly for the first trimester, given
that maternal thyroid hormone dysfunction may affect
optimal development of the fetus [13,14].
Our results are different from those for other studies. Kuri-
oka et al [15] reported significantly reduced levels of free
T3 and free T4 and raised values of TSH as pregnancy pro-
gressed; and Kumar et al [16] reported TSH values that
increased steadily with each trimester, and free T3 and free
T4 values that increased in the first and second trimester
but decreased in the last trimester. Our results are similar,
however, to those reported by Marwaha et al [17], with
the exception of the free T4 values, which, according to
these authors, decreased as gestational age advanced. It
was further observed from our data that only TSH showed
significant differences (P < .005) according to the age of
the mother.
Boxplot. Median value for free triiodothyronine according to gestational age Figure 2
Boxplot. Median value for free triiodothyronine according to gestational age. *P < .05. The circles and stars repre-
sent distant values and outliers, respectively, and the adjacent numbers indicate the gestational week of the patient.
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Boxplot. Median value for free thyroxine according to gestational age Figure 3
Boxplot. Median value for free thyroxine according to gestational age. *P < .05. The circles and stars represent dis-
tant values and outliers, respectively, and the adjacent numbers indicate the gestational week of the patient.
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Table 2: Thyroid Hormone and Thyroid Antibody Values According to Pregnancy Trimester
Pregnancy
Thyroid Hormones/
Antibodies
First Trimester
(<14 weeks)
(n = 481)
Second Trimester
(14 to 28 weeks)
(n = 243)
Third Trimester
(>28 weeks)
(n = 297)
Mean Median 2.5th %ile 97.5th %ile Mean Median 2.5th
%ile
97.5th
%ile
Mean Median 2.5th
%ile
97.5th
%ile
Thyroid-stimulating 
hormone
(μUI/mL)
1.08 ± 
0.69
0.94 0.41 2.63 1.20 ± 
0.62
1.13 0.15 2.59 1.39 ± 
0.75
1.29 0.28 3.48
Free 
triiodothyronine
(pg/mL)
3.41 ± 
0.53
3.42 2.33 4.37 3.33 ± 
0.45
3.34 2.42 4.20 3.22 ± 
0.52
3.24 2.25 4.17
Free thyroxine
(ng/dL)
1.08 ± 
0.14
1.08 0.84 1.38 0.94 ± 
0.12
0.94 0.70 1.16 0.90 ± 
0.13
0.89 0.62 1.17
Thyroid peroxidase 
antibodies
(UI/mL)
0.15 ± 
0.26
0.08 0.00 0.74 0.16 ± 
0.25
0.09 0.00 0.89 0.19 ± 
0.43
0.09 0.00 1.20
Thyroglobulin 
antibodies
(UI/mL)
1.05 ± 
0.65
0.83 0.40 3.12 0.95 ± 
0.62
0.76 0.34 2.65 0.89 ± 
0.51
0.76 0.38 2.48BMC Research Notes 2009, 2:237 http://www.biomedcentral.com/1756-0500/2/237
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Considering the full 9 months of pregnancy, and despite
the fact that there was no evidence of the presence of thy-
roid antibodies or thyroid diseases, we observed 3 cases of
high free T3 values (5.01 pg/mL, 6.09 pg/mL, and 7.1 pg/
mL). For the mother with a free T3 value of 7.1 pg/mL, free
T4 and TSH values were 2.13 ng/dL and 0.0018 μUI/mL,
respectively. As for free T4, 2 first-trimester pregnant
women with no evident pathologies had values of 1.63
ng/dL and 1.75 ng/dL, which, however, returned to nor-
mal levels in the second trimester.
Considering the entire gestational period, we observed 4
cases with free T4 levels above the manufacturer's upper
limit (1.76 ng/dL, 1.75 ng/dL, 1.63 ng/dL, and 1.59 ng/
dL), accompanied by TSH values below the lower limit.
These may be cases of where physiological changes
affected thyroid gland functioning and interpretation of
the thyroid function tests [7,18,19].
Analyzing TSH data, the mean for our population was
below the manufacturer's lower limit (<2.5 μUI/mL), and
there were 5 cases with values above the upper limit (4.17
μUI/mL, 4.30 μUI/mL, 4.33 μUI/mL, 4.48 μUI/mL, and
5.17 μUI/mL); this percentage (0.59%) is lower than that
reported for other studies [20].
The pathologies present in the women without thyroid
antibody disorders were as follows (number of cases in
brackets): hypothyroidism that resolved with treatment
(6); hypothyroidism with gestational diabetes and low
but normal TSH (1); thyroidectomy (1); goiter (2), multi-
nodular goiter (1), cold nodule (1); and gestational diabe-
tes (5).
We found that 177 (14.77%) of the pregnant women were
positive for TPO-Ab and Tg-Ab, indicating a level of
autoimmune diseases of the thyroid in our population
that is very similar to that found in other studies [21-23].
The mean TSH in our population was found to be below
the manufacturer's lower limit (<2.5 μUI/mL); nonethe-
less, similarly to findings in studies by other authors, we
Table 3: Thyroid Hormones Values According to Gestational Age in Pregnant Women With High Thyroid Antibody Values
Thyroid Hormone Gestional Age, wka Mean Median 2.5th
%ile
97.5th
%ile
Thyroid-stimulating hormone (μUI/mL) <11 1.75 ± 3.64 1.25 0.1 13.5
11 to 20 1.63 ± 1.30 1.44 0.0 -
21 to 30 1.89 ± 0.96 1.62 0.4 -
31 to 36 1.72 ± 0.91 1.72 0.2 4.5
>36 1.19 ± 0.62 1.19 0.7 -
Free triiodothyronine (pg/mL) <11 3.31 ± 0.58 3.36 1.7 4.4
11 to 20 3.44 ± 0.65 3.59 1.7 -
21 to 30 3.24 ± 0.51 3.15 2.3 -
31 to 36 3.22 ± 0.47 3.24 2.4 4.3
>36 3.02 ± 0.15 3.02 2.9 -
Free thyroxine (ng/dL) <11 1.06 ± 0.15 1.06 0.8 1.4
11 to 20 1.01 ± 0.15 1.03 0.6 -
21 to 30 0.89 ± 0.97 0.87 0.7 -
31 to 36 0.90 ± 0.13 0.86 0.7 1.3
>36 0.90 ± 0.11 0.90 0.8 -
a <11 weeks (n = 330); 11 to 20 weeks (n = 200); 21 to 30 weeks (n = 208); 31 to 36 weeks (n = 269); >36 weeks (n = 14).BMC Research Notes 2009, 2:237 http://www.biomedcentral.com/1756-0500/2/237
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observed that high TPO-Ab and Tg-Ab values were associ-
ated with an increase in TSH values [24].
Finally, women with high levels of thyroid antibodies had
medical histories as follows (number of cases in brackets):
hypothyroidism (5, of which 2 had a previous history of
miscarriage); thyroidectomy (2); simple goiter (1);
chronic autoimmune thyroiditis (1); hyperthyroidism
(1), thyroidectomy (2); fetal death (3); ectopic pregnancy
(1); gestational diabetes (3); breast fibroadenomas (6),
miscarriage (23); and repeated miscarriage (7).
In conclusion, of the 1198 pregnant women resident in
the Aragon region of Spain analyzed in our study, 85.22%
had normal TPO-Ab and Tg-Ab values and 14.77% tested
positive for autoimmune diseases of the thyroid. In regard
to the population with antibody values that were normal
for the gestational stage, free T4 and TSH values, but not
free T3 values, were statistically different.
The data from this study may be useful in establishing ref-
erence values for our population, in establishing limits in
regard to detecting thyroid diseases such as Graves disease
or Hashimoto thyroiditis, and in evaluating risk to the
fetus or neonate as a result of maternal thyroid dysfunc-
tion.
List of abbreviations
TSH: thyroid-stimulating hormone; T3: triiodothyronine;
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Ab: thyroglobulin antibody; RLU: relative light unit.
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